Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study

BACKGROUND: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a fatal condition without an established pharmaceutical treatment. Most patients are treated with high-dose corticosteroids and broad-spectrum antibiotics. Azithromycin is a macrolide with immunomodulatory activity and may...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Kodai, Ichikado, Kazuya, Yasuda, Yuko, Anan, Keisuke, Suga, Moritaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477160/
https://www.ncbi.nlm.nih.gov/pubmed/28629448
http://dx.doi.org/10.1186/s12890-017-0437-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477160/
https://www.ncbi.nlm.nih.gov/pubmed/28629448
http://dx.doi.org/10.1186/s12890-017-0437-z

Ejemplares similares